Cleared Traditional

K173263 - Xpert Carba-R (FDA 510(k) Clearance)

Jan 2018
Decision
90d
Days
Class 2
Risk

K173263 is an FDA 510(k) clearance for the Xpert Carba-R. This device is classified as a System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen (Class II - Special Controls, product code POC).

Submitted by Cepheid (Sunnyvale, US). The FDA issued a Cleared decision on January 9, 2018, 90 days after receiving the submission on October 11, 2017.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.1640. To Detect The Presence Of Genetic Markers Of Antimicrobial Resistance By Testing Directly From Clinical Specimens Using Nucleic Acid Amplification Technology..

Submission Details

510(k) Number K173263 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 11, 2017
Decision Date January 09, 2018
Days to Decision 90 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code POC — System, Nucleic Acid Amplification Test, Dna, Antimicrobial Resistance Marker, Direct Specimen
Device Class Class II - Special Controls
CFR Regulation 21 CFR 866.1640
Definition To Detect The Presence Of Genetic Markers Of Antimicrobial Resistance By Testing Directly From Clinical Specimens Using Nucleic Acid Amplification Technology.